ziyad al aly glp 1 Al-Aly | Office of Neuroscience Research GLP-1 Agents' Risks and Benefits

Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E

Their program emphasizes sustainable results through metabolic health optimization

The secondary cardiovascular outcome was the composite of cardiovascular death, non-fatal myocardial infarction and non-fatal ischaemic stroke

EXPERTS CAUTION AGAINST UNSUPERVISED USE Despite their effectiveness, experts warn against the unsupervised use of these powerful drugs

Disclosures N.I

The clinical research , the neurological mechanisms, the psychological factors that masquerade as medication side effects, and the practical strategies for managing anxiety while on tirzepatide